查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1970816

全球脱髮治疗产品市场－按产品类型、最终用户、分销管道、地区和竞争格局分類的行业规模、份额、趋势、机会和预测（2021-2031年）

Hair Loss Treatment Product Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Product Type, By End User, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球除毛疗程产品市场预计将从 2025 年的 28.5 亿美元成长到 2031 年的 46.6 亿美元，复合年增长率为 8.54%。

该领域涵盖多种旨在缓解脱髮症和促进毛囊再生的解决方案，包括外用製剂、口服药物、低功率雷射治疗设备和整装仪容辅助器具。推动该行业发展的关键因素包括：全球人口老化导致男性型脱髮症（雄性脱毛症）风险增加；可支配收入的增长使人们能够负担得起特定的美容治疗；以及人们对个人仪容仪表的日益重视。这些经济和生物学因素创造了持续的需求，确保了稳定的收入来源，这与短暂的消费趋势或短暂的时尚潮流截然不同。

市场概览
预测期 2027-2031
市场规模：2025年 28.5亿美元
市场规模：2031年 46.6亿美元
复合年增长率：2026-2031年 8.54%
成长最快的细分市场 女士
最大的市场 北美洲

然而，不受监管的黑市诊所的兴起带来了严峻挑战，威胁着病人安全，并削弱了消费者对核准治疗通讯协定的信任。这个问题使法规环境复杂化，并可能阻碍合法、经临床检验的解决方案的推广应用。儘管存在这些障碍，该领域仍在持续发展。根据国际毛髮修復外科学会（ISHRS）的数据，到2025年，每位会员医师平均接诊的患者数量将比2021年增加20%。这一增长表明，越来越多的患者正在积极寻求毛髮再生的专业治疗。

市场驱动因素

直接面向消费者 (DTC) 管道和远端医疗平台的扩张，从根本上改变了市场进入，减少了与脱髮咨询相关的社会污名，并简化了处方笺配送流程。这些以数位化为先导的生态系统绕过了传统的临床障碍，提供符合现代人对便利性和隐私性偏好的私密、个人化治疗方案。透过将非同步医疗咨询与订阅式产品配送相结合，它们成功地吸引了此前无法获得标准皮肤科护理的年轻、精通科技的人群。这种结构性转变体现在市场领导的财务成功上。例如，Hims & Hers Health, Inc. 在 2025 年 11 月发布的 2025 年第三季财报中揭露，其季度营收为 5.99 亿美元，这主要得益于寻求个人化健康解决方案的线上用户激增。

同时，新型药物製剂和生物製药，特别是Janus激酶 (JAK) 抑制剂的引入，为重度自体免疫脱髮症的治疗带来了新的希望。传统的局部治疗往往效果不稳定，而这些先进的生物疗法则针对脱髮症等疾病的潜在免疫通路，展现出卓越的疗效，并提高了患者的依从性和支付意愿。为了支持这项临床进展，太阳製药工业公司在 2025 年 7 月发布的新闻稿中宣布，随着 LEQSELVI 在美国上市，临床试验中 33% 的患者在 24 週时几乎完全恢復了头皮毛髮。这项创新治疗方法满足了重要的未满足医疗需求。根据美国脱髮症) 预测，到 2025 年，美国将有约 70 万人患有脱髮症，这代表着下一代疗法的巨大市场潜力。

市场挑战

不受监管的黑市诊所的扩张对全球除毛治疗产品市场的持续成长构成重大障碍。这些非法机构通常会僱用无证技师以低价进行精细的外科手术，往往导致严重的疤痕、感染疾病和外观不自然等不良后果。此类不利事件会严重损害除毛疗程的声誉，削弱消费者对除毛治疗有效性和安全性的信心。因此，整体患者可能会对治疗产生恐惧，并犹豫是否选择有资格的医疗专业人员或核准的治疗产品。这可能会阻碍合法相关人员的市场渗透和收入成长。

近期行业数据显示，无证诊所普遍存在，凸显了问题的严重性。国际毛髮修復外科学会（ISHRS）预测，到2025年，59%的会员医师将报告其所在地区有活跃的黑市诊所。如此高的氾滥程度迫使合法产业疲于应对声誉损害，并将资源投入到纠正措施中，而非专注于市场扩张和创新。

市场趋势

头髮护理的「皮肤化」正在从根本上改变产品开发。製造商们正在重新设计洗髮精和精华液，优先考虑维持头皮微生物群的平衡和屏障功能。这种方法与脸部护肤类似。这种模式转移将头皮视为皮肤的延伸，并融入了透明质酸、水杨酸和益生菌等活性成分。它超越了简单的头髮表面护理，从细胞层面改善毛囊健康。这种将日常整装仪容提升至医学水平的方法正在推动皮肤化妆品品牌实现显着的收入成长。根据欧莱雅集团于2025年2月发布的《2024财年报告》，其皮肤化妆品部门（包括薇姿等头皮护理品牌）的销售额达到70亿欧元，较去年同期成长9.8%。

同时，口服营养补充品市场正在发生决定性的转变。这主要源自于消费者逐渐认识到自身整体健康状况（尤其是压力、荷尔蒙平衡和营养状况）与头髮活力之间的关联。这一趋势支撑着「由内而外滋养美丽」的概念，即从被动的药物干预转向预防性的日常营养保健疗法，利用植物性适应原和标准化临床维生素。该领域的商业性前景十分广阔。根据联合利华于2025年2月发布的“2024财年业绩报告”，在Nutrafol等高端品牌的推动下，其美容与健康业务部门实现了6.5%的销售额增长。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球脱髮治疗产品市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（洗髮精和护髮素、精华液、精油、其他）
    • 按最终用户（男性、女性）
    • 分销通路（线上、线下）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美脱髮治疗产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲脱髮治疗产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区脱髮治疗产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲脱髮治疗产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲脱髮治疗产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球脱髮治疗产品市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • The Procter & Gamble Company
  • Loreal SA
  • Unilever Plc
  • Taisho Pharmaceutical Holdings Co., Ltd
  • Pierre Fabre SA
  • The Man Company
  • Net Distribution Services Private Limited
  • Guiltfree Industries Limited
  • Sebamed
  • L'Occitane

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27994

The Global Hair Loss Treatment Product Market is projected to expand from USD 2.85 Billion in 2025 to USD 4.66 Billion by 2031, registering a CAGR of 8.54%. This sector encompasses a range of solutions, including topical formulations, oral medications, low-level laser therapy devices, and surgical aids designed to alleviate alopecia and encourage follicular regrowth. Key drivers fueling this industry include an aging global population increasingly prone to androgenetic alopecia, rising disposable incomes that facilitate access to elective aesthetic treatments, and heightened social awareness regarding personal grooming. These underlying economic and biological factors provide sustained demand and ensure reliable revenue streams, distinct from temporary consumer fads or fleeting style trends.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.85 Billion
Market Size 2031USD 4.66 Billion
CAGR 2026-20318.54%
Fastest Growing SegmentWomen
Largest MarketNorth America

However, the rise of unregulated black market clinics presents a serious challenge by endangering patient safety and diminishing consumer trust in approved therapeutic protocols. This issue complicates the regulatory environment and may hinder the adoption of legitimate, clinically validated solutions. Despite these obstacles, the sector continues to grow; according to the International Society of Hair Restoration Surgery, the average number of patients treated per member physician rose by 20% in 2025 compared to 2021. This increase indicates a broadening patient base that is actively seeking professional interventions for hair restoration.

Market Driver

The expansion of Direct-to-Consumer (DTC) channels and telemedicine platforms is fundamentally transforming market access by reducing the stigma associated with hair loss consultations and simplifying prescription delivery. These digital-first ecosystems enable consumers to bypass traditional clinical hurdles, offering discreet, personalized treatment plans that align with the modern preference for convenience and privacy. By combining asynchronous medical consultations with subscription-based product fulfillment, these platforms have successfully attracted a younger, tech-savvy demographic that previously fell outside standard dermatological care. This structural shift is reflected in the financial success of market leaders; for instance, Hims & Hers Health, Inc. reported in its November 2025 "Third Quarter 2025 Financial Results" that quarterly revenue reached $599 million, driven largely by a surge in online subscribers seeking personalized health solutions.

Simultaneously, the introduction of novel drug formulations and biologic treatments, particularly Janus kinase (JAK) inhibitors, is revitalizing the therapeutic landscape for severe autoimmune hair disorders. Unlike conventional topical solutions that often produce variable results, these advanced biologic therapies target the immune pathways underlying conditions like alopecia areata, offering superior efficacy that encourages higher patient adherence and willingness to pay. Validating this clinical progress, Sun Pharmaceutical Industries Limited announced in a July 2025 press release regarding the U.S. launch of LEQSELVI that clinical trials showed 33% of patients regained almost all their scalp hair by week 24. This innovation meets a critical unmet need; according to the National Alopecia Areata Foundation, alopecia areata affects approximately 700,000 people in the United States in 2025, representing a significant market for these next-generation therapeutics.

Market Challenge

The spread of unregulated black market clinics acts as a formidable barrier to the sustained expansion of the Global Hair Loss Treatment Product Market. These illicit operations often employ unlicensed technicians to perform delicate surgical procedures at reduced costs, frequently resulting in substandard outcomes such as severe scarring, infections, or unnatural aesthetics. Such adverse events generate significant negative publicity that severely erodes consumer trust in the efficacy and safety of hair restoration. Consequently, potential patients may develop a generalized fear of treatment, hesitating to engage with legitimate medical professionals or approved therapeutic products, thereby stalling broader market adoption and revenue growth for compliant stakeholders.

The magnitude of this issue is evidenced by recent industry data highlighting the widespread reach of these unauthorized entities. According to the International Society of Hair Restoration Surgery, 59% of member physicians reported the active presence of black market clinics operating within their local municipalities in 2025. This high prevalence forces the legitimate industry to combat reputational damage and divert resources toward corrective interventions rather than focusing purely on market expansion and innovation.

Market Trends

The "skinification" of hair care is fundamentally altering product development, as manufacturers reformulate shampoos and serums to prioritize scalp microbiome balance and barrier function, similar to facial skincare. This paradigm shift treats the scalp as an extension of the skin, integrating active ingredients such as hyaluronic acid, salicylic acid, and probiotics to address follicular health at the cellular level rather than merely treating the hair shaft. This medicalized approach to daily grooming is driving substantial revenue gains for dermocosmetic brands; according to L'Oreal S.A.'s "2024 Annual Results" from February 2025, the Dermatological Beauty division, which houses scalp-focused brands like Vichy Dercos, reported like-for-like sales growth of 9.8% to reach €7 billion.

Simultaneously, there is a decisive market shift toward holistic ingestible supplements, driven by consumers recognizing the link between internal systemic health-specifically stress, hormonal balance, and nutrition-and hair vitality. This trend validates the "beauty-from-within" concept, moving beyond reactive pharmaceutical interventions to preventative, daily nutraceutical regimens that utilize botanical adaptogens and standardized clinical vitamins. The commercial viability of this segment is robust; according to Unilever PLC's "Full Year 2024 Results" in February 2025, the Beauty & Wellbeing business group, driven by prestige brands like Nutrafol, delivered underlying sales growth of 6.5%.

Key Market Players

  • The Procter & Gamble Company
  • Loreal S.A.
  • Unilever Plc
  • Taisho Pharmaceutical Holdings Co., Ltd
  • Pierre Fabre S.A.
  • The Man Company
  • Net Distribution Services Private Limited
  • Guiltfree Industries Limited
  • Sebamed
  • L'Occitane

Report Scope

In this report, the Global Hair Loss Treatment Product Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hair Loss Treatment Product Market, By Product Type

  • Shampoo & Conditioner
  • Serum
  • Oil
  • Others

Hair Loss Treatment Product Market, By End User

  • Men
  • Women

Hair Loss Treatment Product Market, By Distribution Channel

  • Online
  • Offline

Hair Loss Treatment Product Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hair Loss Treatment Product Market.

Available Customizations:

Global Hair Loss Treatment Product Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hair Loss Treatment Product Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Shampoo & Conditioner, Serum, Oil, Others)
    • 5.2.2. By End User (Men, Women)
    • 5.2.3. By Distribution Channel (Online, Offline)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Hair Loss Treatment Product Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hair Loss Treatment Product Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Hair Loss Treatment Product Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Hair Loss Treatment Product Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Distribution Channel

7. Europe Hair Loss Treatment Product Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hair Loss Treatment Product Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Hair Loss Treatment Product Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Hair Loss Treatment Product Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Hair Loss Treatment Product Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Hair Loss Treatment Product Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Hair Loss Treatment Product Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hair Loss Treatment Product Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Hair Loss Treatment Product Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Hair Loss Treatment Product Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Hair Loss Treatment Product Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Hair Loss Treatment Product Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Hair Loss Treatment Product Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hair Loss Treatment Product Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Hair Loss Treatment Product Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Hair Loss Treatment Product Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Distribution Channel

10. South America Hair Loss Treatment Product Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hair Loss Treatment Product Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Hair Loss Treatment Product Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Hair Loss Treatment Product Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hair Loss Treatment Product Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. The Procter & Gamble Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Loreal S.A.
  • 15.3. Unilever Plc
  • 15.4. Taisho Pharmaceutical Holdings Co., Ltd
  • 15.5. Pierre Fabre S.A.
  • 15.6. The Man Company
  • 15.7. Net Distribution Services Private Limited
  • 15.8. Guiltfree Industries Limited
  • 15.9. Sebamed
  • 15.10. L'Occitane

16. Strategic Recommendations

17. About Us & Disclaimer